Trials / Unknown
UnknownNCT04379440
Geriatric Population COVID-19 Observational Study (GEROCOVIDobs)
Geriatric Population COVID-19 Syndromic Characteristics and Clinical Outcomes: a Multi-setting, Multi-domain Observational Study (GEROCOVID Observational)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (estimated)
- Sponsor
- Raffaele Antonelli Incalzi · Academic / Other
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Not accepted
Summary
The GeroCovid e-Registry is a European de-identified clinical data electronic registry of geriatric patients at risk or suffering from COVID-19 (suspected and confirmed cases) observed since 1st March 2020 in the participating investigational sites.
Detailed description
Older adults (≥ 65 years) and pre-geriatric population (≥60 years and \<65 years) are the ones most at risk from complications of COVID-19, including increased mortality, possibly in relationship with their comorbidity and frailty status. The GeroCovid e-registry is intended to track Covid-19 pandemic impact on the general geriatric population and on age/care-setting related sub-populations. The analysis of results is expected to facilitate the adoption of optimal standard of geriatric care during the pandemic.
Conditions
Timeline
- Start date
- 2020-04-25
- Primary completion
- 2020-09-30
- Completion
- 2020-11-30
- First posted
- 2020-05-07
- Last updated
- 2020-05-07
Locations
7 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT04379440. Inclusion in this directory is not an endorsement.